Agenda | MedTech World Asia

Positioning HK as a launchpad into Mainland China, Southeast Asia, and beyond. Leaders explore why HK’s regulatory environment, capital markets, and GBA proximity make it uniquely suited for MedTech companies seeking regional scale.

Expanding across Asia is not a one-size-fits-all playbook. This session dives into the practical realities of entering and scaling across multiple APAC markets, covering regulatory sequencing, localization, partnerships, and go-to-market strategies needed to succeed in diverse healthcare systems.

Procurement, tendering, and reimbursement realities in China, Japan, Singapore, and beyond. Health system insiders and MedTech executives break down what it actually takes to get listed, funded, and adopted within Asian public healthcare frameworks.

Presenting Slot

How Southeast Asian MedTech funding trends diverge from US and European markets. This panel examines investor risk appetite, deal structures, due diligence expectations, and the cultural nuances that shape how capital flows to innovation in Asia.

When corporate investment makes more sense than VC for MedTech scale-up. This panel explores CVC relationships, strategic partnership structures, and non-dilutive funding options that let companies accelerate growth without sacrificing control.

Presenting Slot

This panel explores how AI is transforming complex health data—such as genomics, imaging, and real-world evidence—into actionable insights for more personalized care. Experts will discuss real-world applications, challenges, and how we can accelerate the shift toward delivering the right treatment to the right patient at the right time.

Designing products for markets with varying connectivity, data regulation, and digital literacy. This panel explores how to build digital health solutions that work across Asia’s diverse infrastructure conditions, from tier-1 cities to rural populations.

How the GBA policy framework, Shenzhen’s manufacturing base, and HK’s regulatory gateway create a unique launchpad for global MedTech companies. Panelists discuss practical strategies for navigating cross-border operations within the GBA.

Leading APAC VCs and family offices discuss investment priorities, what’s attracting capital across the region, and what founders misunderstand about raising from Asian investors. A candid look at which sectors and geographies are generating the strongest interest.

Which markets are leading adoption, who is funding it, and what the competitive landscape looks like. From Japan to China to Southeast Asia, this panel maps where surgical robotics is taking hold and what it takes to win in this high-stakes space.

Presenting Slot

What separates funded startups from those that truly scale? Investors, founders, and accelerators share practical insights on validation, regulation, market entry, and execution across Asia.

From diagnostics to therapeutics, what regional health systems are prioritising in women’s health. This panel examines the commercial opportunity, clinical evidence requirements, and cultural factors shaping FemTech adoption across Asian markets.

What it takes to scale manufacturing and commercial teams in the region. Leaders share how to build resilient supply chains, hire and retain local talent, and manage the operational complexity of scaling across multiple Asian jurisdictions.

Presenting Slot

India is rapidly emerging as a serious MedTech innovation hub. With a massive patient population, PLI manufacturing incentives, and a maturing CDSCO regulatory framework, this panel explores what it takes to enter, scale, or partner in India.